Ayala Pharmaceuticals Inc (ADXS)

[Gantor50]

Also absolutely agreed. While at least we have a restored partial uptick rule, it is quite lame in offering protection to micro cap Biotech stocks like ADXS.

In fact, the reason we can all know for a virtual certainty that the price collapse since June has largely been a short selling attack...and not institutions dumping en masse...is the careful protection of the uptick rule. They have been very careful to keep it from getting invoked. The point is to drag out and elongate the selling to wear down retail and force margin calls on almost every single share of ADXS out there that was on margin.

Here is a great brief synopsis of the uptick rule from SEC.GOV...

https://www.sec.gov/comments/s7-08-09/s70809-1388.pdf